Overview

Alzheimer's in Long-Term Care--Treatment for Agitation

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.
Phase:
N/A
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute on Aging (NIA)
Treatments:
Prazosin